当前位置: X-MOL 学术Eur. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Three Years After CARMENA: What Have We Learned?
European Urology ( IF 23.4 ) Pub Date : 2021-07-27 , DOI: 10.1016/j.eururo.2021.07.007
Eduard Roussel 1 , Benoit Beuselinck 2 , Maarten Albersen 1
Affiliation  

Cytoreductive nephrectomy makes way for more effective systemic treatments in the current mRCC treatment paradigm, as disease volume and the number of IMDC risk factors increase. Careful patient selection for upfront or deferred cytoreductive nephrectomy based on these criteria remains key.



中文翻译:

CARMENA 三年后:我们学到了什么?

随着疾病数量和 IMDC 危险因素数量的增加,细胞减灭性肾切除术在当前的 mRCC 治疗范式中为更有效的全身治疗铺平了道路。根据这些标准仔细选择患者进行前期或延迟细胞减灭术肾切除术仍然是关键。

更新日期:2021-07-27
down
wechat
bug